healthcare stocks wall street PHGRF

Biotechnology has proved to be one of the most fruitful areas when it comes to stocks. Many of these can quickly double or even triple in value seemingly overnight. The main reason is that the stock market simply cannot predict the success of clinical trials with any degree of accuracy whatsoever.

However, the biotech sector has attracted many investors. They have managed to grow their wealth by picking the right stocks from this arena. On that note, here is a look at two biotech stocks that are worth considering.

Biotech Stocks Gaining Momentum in Early 2020 #1 Can-Fite BioPharma

The first biotech stock to watch is that of Can-Fite BioPharma Ltd. (NYSE:CANF). It has soared significantly on Friday’s trade after the company made a major announcement. The company announced highly encouraging preclinical data with regards to its anti-obesity product CF 102 (Namodenoson).

biotech stocks to watch CanFite CANF

After the announcement was made by Can-Fite, investors piled on to the stock on Friday and it soared by as much as 13% to $3.52. It goes without saying that Can-Fite has emerged as one of the stocks to watch in the short term. It should also be noted that Can-Fite has already applied for a patent for the product at the World Intellectual Property Organization.

Biotech Stocks Gaining Momentum in Early 2020 #2 Leap Therapeutics

The other biotech stock that has gone on an amazing rally this month is Leap Therapeutics Inc (NASDAQ:LPTX). The company announced that it signed a licensing and exclusive option agreement with BeiGene for its product DKN-01. BeiGene is going to pay $3 million upfront for the same and the total milestone payments could go up to as much as $132 million in the end.

BeiGene has taken up the rights of Asia (barring Japan), New Zealand and Australia. In addition to that, Leap has also attracted equity investment to the tune of $27 million from BeiGene and two institutional investors. The stock has soared by as much as 52.61% on Friday’s trading session.

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

The $40 Billion Dollar Content Gold Rush

Apple, Disney, Netflix, Amazon, NBC, Hulu & More are All Competing Within the Global Video Streaming Market and They All Need the Same Thing…

1 Biotech Stock is Positioning Itself for Success

Biotech has always been one of the best performing sectors in the market. A number of biotech stocks have produced life-changing returns because of their treatments and opportunities. You wont believe what this 1 stock is doing…

What Curing Cancer & HIV Could Mean for This Company, Its Investors & The World!

The opportunity for companies within this sector is massive we are now talking about an industry that is currently worth over US$ 100 billion with the potential in the next 6.5 years to be worth over US$ 200 billion.

1 Stock is Positioning to Disrupt a Billion Dollar Industry Creating Opportunity & Saving Lives

The Weapons Detection market is expected to grow to nearly $7.5 billion by 2025 and for investors, it could signal big opportunities.